Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A post hoc analysis performed in emergency departments
ObjectivesCopeptin and high-sensitivity cardiac troponin (HS-cTn) assays improve the early detection of non-ST-segment elevation myocardial infarction (NSTEMI). Their sensitivities may, however, be reduced in very early presenters.SettingWe performed a post hoc analysis of three prospective studies...
Main Authors: | Nicolas Peschanski, Camille Chenevier-Gobeaux, Mustapha Sebbane, Christophe Meune, Sophie Lefebvre, Anne-Marie Dupuy, Guillaume Lefèvre, Patrick Ray |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/9/6/e023994.full |
Similar Items
-
Multi-centre evaluation of recent troponin assays for the diagnosis of NSTEMI
by: Camille Chenevier-Gobeaux, et al.
Published: (2018-07-01) -
Comparison of Troponin, High-Sensitivity Troponin, and Copeptin Markers at Different Times in Patients with High-Risk Chest Pain
by: Alireza Abootalebi, et al.
Published: (2019-08-01) -
Copeptin with high-sensitivity troponin at presentation is not inferior to serial troponin measurements for ruling out acute myocardial infarction
by: Kyung Su Kim, et al.
Published: (2020-03-01) -
High-sensitivity troponin I with or without ultra-sensitive copeptin for the instant rule-out of acute myocardial infarction
by: Fabrizio Ricci, et al.
Published: (2022-08-01) -
High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study
by: Gillian Divard, et al.
Published: (2017-06-01)